PIVOTAL BIOVENTURE PARTNERS
PIVOTAL BIOVENTURE PARTNERS is a Pre-seed, Seed, Series A, Series B and Series C+ fund in the US, Europe and Greater China writing $1M–$50M checks into AI, Healthcare and drug-discovery.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- AI, Healthcare, drug-discovery
- Check size
- $1M–$50M
- Invests in
- US-wide, Europe, Greater China
- Actively investing
- Yes
- Founded
- 2017
- Assets under management
- $689M
Thesis
Pivotal BioVenture Partners is a life sciences venture capital firm established in 2017, operating as the venture capital arm of Pivotal Life Sciences, which is part of the Nan Fung Group. The firm has a global presence with offices in San Francisco, California; Boston, Massachusetts; Shanghai, and Hong Kong. Pivotal BioVenture Partners focuses on investing in transformative therapeutic innovations that address significant unmet medical needs. Their investment strategy spans various stages, from company creation and seed funding through Series A, B, C, and growth equity. They are open to leading or co-leading transactions. The firm primarily focuses on North America, Europe, and Greater China, seeking to leverage deep expertise, a worldwide network, and a long-term vision to improve human health. They are particularly interested in companies utilizing AI and data analytics to enhance their processes. Fund I, established in 2017, raised $300 million. In December 2023, the firm announced the closing of its second fund, Fund II, with $389 million in capital commitments, bringing the total capital commitments to $689 million. The Nan Fung Group, under which Pivotal BioVenture Partners operates, has over $3 billion in total assets under management across all Nan Fung Life Sciences vehicles. The typical check size per investment deal ranges from $1 million to $50 million, with a sweet spot of $20 million. They also indicate an average investment range of $20M - $50M, and $50M+.
Common questions
Does PIVOTAL BIOVENTURE PARTNERS invest at the Pre-seed stage?
Yes. PIVOTAL BIOVENTURE PARTNERS lists Pre-seed, Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does PIVOTAL BIOVENTURE PARTNERS write?
PIVOTAL BIOVENTURE PARTNERS writes $1M–$50M checks.
Where does PIVOTAL BIOVENTURE PARTNERS invest?
PIVOTAL BIOVENTURE PARTNERS invests in the US, Europe and Greater China.